Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$110.31 - $140.45 $22.4 Million - $28.5 Million
203,043 Added 14.36%
1,617,001 $183 Million
Q1 2024

Apr 18, 2024

BUY
$114.22 - $140.1 $28.3 Million - $34.8 Million
248,111 Added 21.28%
1,413,958 $196 Million
Q4 2023

Jan 24, 2024

SELL
$75.49 - $124.16 $22.2 Million - $36.5 Million
-293,883 Reduced 20.13%
1,165,847 $145 Million
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $125 Million - $200 Million
1,451,165 Added 16942.97%
1,459,730 $136 Million
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $22,494 - $26,195
-200 Reduced 2.28%
8,565 $1.1 Million
Q1 2023

May 05, 2023

BUY
$104.0 - $122.92 $484,640 - $572,807
4,660 Added 113.52%
8,765 $1.02 Million
Q4 2022

Jan 30, 2023

SELL
$84.98 - $122.67 $220,523 - $318,328
-2,595 Reduced 38.73%
4,105 $465,000
Q3 2022

Nov 04, 2022

SELL
$76.35 - $94.18 $363,426 - $448,296
-4,760 Reduced 41.54%
6,700 $540,000
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $662,562 - $1.3 Million
9,745 Added 568.22%
11,460 $854,000
Q1 2022

May 04, 2022

BUY
$94.08 - $130.2 $161,347 - $223,292
1,715 New
1,715 $877,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.